Hiroko Takenouchi
Research Subjects
Hiroko Takenouchi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Hiroaki Nagano
Department of Gastroenterological, Breast, and Endocrine Surgery Yamaguchi University Graduate School of Medicine Yamaguchi Japan
2 shared publications - Nobuaki Suzuki
Department of Gastroenterological, Breast and Endocrine Surgery Yamaguchi University Graduate School of Medicine Ube Yamaguchi Japan
2 shared publications - Ryouichi Tsunedomi
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan
2 shared publications - Hideyoshi Kawasaki
Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
1 shared publication - Hideyuki Yamawaki
Lab. Vet Pharmacol., Sch. Vet. Med., Kitasato Univ
1 shared publication - Kazuaki Sasaki
Dept. Vet Med., Fac. agr., Tokyo Univ of Agr and Tech
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-232
Elucidation of mechanism of growth inhibition of human colorectal stem cell by dietary polyphenol antioxidant.
【Background】Polyphenol compounds in foods contain antioxidants and are known to have effects of liver protection, hypoglycemic, and cholesterol-lowering. Colorectal cancer is one of the most types of cancers and the mortality rate is the second-highest in Japan. Since cancer stem cells are related to drug resistance and recurrence of colorectal cancer, a new remedy that targets cancer stem cells is needed. In the previous study, we established a novel culture method of the human colorectal air-liquid interface (ALI) organoids, which could recapitulate three-dimensional cancer microenvironment including patient-derived cancer stem cells. In this study, we investigated whether polyphenol antioxidants affect the survival rate of human colorectal ALI organoids and analyzed the inhibitory mechanisms.【Methods and results】Organoids were treated with polyphenol antioxidants at the dose of 3-100 μg/ml for 72 hours. The survival rate of organoids was measured by alamarblue assay. Polyphenol antioxidants suppressed survival rate of organoids in a concentration-dependent manner. The expression of marker genes for cancer stem cells, LGR5 and PROM1 were drastically decreased by polyphenol antioxidants. Expression of a G1/S transition-related gene, CCND1 was also decreased.【Conclusion】These results suggest that polyphenol antioxidants inhibit proliferation of human colorectal cancer stem cells via suppression of LGR5, PROM1, and CCND1, which might lead to the development of dietary supplements targeting colorectal cancer stem cells.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-232
Open AccessElucidation of mechanism of growth inhibition of human colorectal stem cell by dietary polyphenol antioxidant.
【Background】Polyphenol compounds in foods contain antioxidants and are known to have effects of liver protection, hypoglycemic, and cholesterol-lowering. Colorectal cancer is one of the most types of cancers and the mortality rate is the second-highest in Japan. Since cancer stem cells are related to drug resistance and recurrence of colorectal cancer, a new remedy that targets cancer stem cells is needed. In the previous study, we established a novel culture method of the human colorectal air-liquid interface (ALI) organoids, which could recapitulate three-dimensional cancer microenvironment including patient-derived cancer stem cells. In this study, we investigated whether polyphenol antioxidants affect the survival rate of human colorectal ALI organoids and analyzed the inhibitory mechanisms.【Methods and results】Organoids were treated with polyphenol antioxidants at the dose of 3-100 μg/ml for 72 hours. The survival rate of organoids was measured by alamarblue assay. Polyphenol antioxidants suppressed survival rate of organoids in a concentration-dependent manner. The expression of marker genes for cancer stem cells, LGR5 and PROM1 were drastically decreased by polyphenol antioxidants. Expression of a G1/S transition-related gene, CCND1 was also decreased.【Conclusion】These results suggest that polyphenol antioxidants inhibit proliferation of human colorectal cancer stem cells via suppression of LGR5, PROM1, and CCND1, which might lead to the development of dietary supplements targeting colorectal cancer stem cells.
- Open Access
- 1 January 2016
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 7053872
Establishment of a Novel Model for Anticancer Drug Resistance in Three‐Dimensional Primary Culture of Tumor Microenvironment
Tumor microenvironment has been implicated in tumor development and progression. As a three‐dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from tissues of colorectal cancer patients has not been established. Here, we developed an ALI organoid model from normal and tumor colorectal tissues of human patients. Both organoids were successfully generated and showed cystic structures containing an epithelial layer and surrounding mesenchymal stromal cells. Structures of tumor organoids closely resembled primary tumor epithelium. Expression of an epithelial cell marker, E‐cadherin, a goblet cell marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast marker, α‐smooth muscle actin (SMA), was observed in normal organoids. Expression of E‐cadherin, MUC2, vimentin, and α‐SMA was observed in tumor organoids. Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. Tumor organoids were more resistant to toxicity of 5‐fluorouracil and Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116. These findings indicate that ALI organoid culture from colorectal cancer patients may become a novel model that is useful for examining resistance to chemotherapy in tumor microenvironment.
- 1 January 2016
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 7053872
Open AccessEstablishment of a Novel Model for Anticancer Drug Resistance in Three‐Dimensional Primary Culture of Tumor Microenvironment
Tumor microenvironment has been implicated in tumor development and progression. As a three‐dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from tissues of colorectal cancer patients has not been established. Here, we developed an ALI organoid model from normal and tumor colorectal tissues of human patients. Both organoids were successfully generated and showed cystic structures containing an epithelial layer and surrounding mesenchymal stromal cells. Structures of tumor organoids closely resembled primary tumor epithelium. Expression of an epithelial cell marker, E‐cadherin, a goblet cell marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast marker, α‐smooth muscle actin (SMA), was observed in normal organoids. Expression of E‐cadherin, MUC2, vimentin, and α‐SMA was observed in tumor organoids. Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. Tumor organoids were more resistant to toxicity of 5‐fluorouracil and Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116. These findings indicate that ALI organoid culture from colorectal cancer patients may become a novel model that is useful for examining resistance to chemotherapy in tumor microenvironment.